GENERAL COMMENTS
I read with interest the paper entitled: FIRST-line support for Assistance in Breathing in Children (FIRST-ABC): protocol for a multicentre randomised feasibility trial of non-invasive respiratory support in critically ill children. It is a clear, well written protocol for a RCT with an important aim: to determine the efficacy of two non invasive respiratory support techniques in PICU. I also appreciated the effort to detect parents stress and their emotional status. I do not have major comments but only few minor questions. 1. Why the authors did not consider the helmet as an alternative interface for CPAP but they just considered nasal or face prongs and mask ? 2. Why did they set the maximum peep level for CPAP arm at 8 cm H2O and not higher (10 for example) ? 3. Did the authors think it is unnecessary to use in the protocol a specific well defined scale to determine the worsening or improvement of respiratory distress (for example the modified Wood's Clinical Asthma Score) ? 4. In the protocol, clinical management paragraph, they stated that "…all other treatment in both groups will be as per standard practice in the studies sites." Did they include analgo sedation ? Although it is not necessary most of the times for HFNC, sometimes it might increase patient compliance when CPAP is administered through any other interface, or at least it represent an option that might change widely from one center to another . If analgo sedation is an option, I think that it should be specified in the data collection if, when and how it was used.
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GENERAL COMMENTS
Very well written and thought through. However there are a couple of comments. The final paragraph on page 9 is very unwieldy and difficult to understand -could this please be rewritten. In Figure 3 , lines 33-34, I am unclear what the pressure is being weaned to/by. Could this please be clarified. I am unsure why you are using the PSS:PICU as it doesn't appear to be answering any of the study objectives.
The section on data analysis doesn't really address how data is planned to be analysed.
VERSION 1 -AUTHOR RESPONSE
REVIEWER #1 1. Why the authors did not consider the helmet as an alternative interface for CPAP but they just considered nasal or face prongs and mask? >> This was a pragmatic trial, hence CPAP could be provided through any interface -there was no specific requirement in the protocol to use one interface or the other. In general, most UK PICUs use nasal prongs or face mask to provide CPAP; very few PICUs in the UK use the helmet interface. In the three PICUs that participated in the FIRST ABC feasibility trial, only one had the capability to use the helmet interface.
2. Why did they set the maximum peep level for CPAP arm at 8 cm H2O and not higher (10 for example)? >> We set the maximum PEEP level for CPAP as per current practice in UK PICUs as well as based on the available evidence. For example, Essouri et al (2011) studied the optimal PEEP level in infants with bronchiolitis and found that a CPAP level of 7 cm H2O was associated with the greatest unloading of the respiratory muscles and improvement of breathing pattern, as well as a favourable short-term clinical outcome. A PEEP of 10 cm H2O was associated with an increase in work of breathing parameters compared to 7 cm H2O.
3. Did the authors think it is unnecessary to use in the protocol a specific well defined scale to determine the worsening or improvement of respiratory distress (for example the modified Wood's Clinical Asthma Score)? >> We had considered the use of an objective scale such as the modified Wood's Clinical Asthma Score (mWCAS) or equivalent scale. However, while the WCAS has been validated for use in children with asthma and used in infants with bronchiolitis, it has not been validated in other conditions or for older age groups. Since we were recruiting children of varying ages with a wide range of diseases, the use of a single score was not felt to be feasible. Instead, we classified patients into no respiratory distress, mild, moderate and severe respiratory distress, using the following clinical definitions:
-None -no accessory muscle use, no subcostal/intercostal recession, not tachypnoeic for age, and no grunting -Mild -one accessory muscle used, mild indrawing of subcostal and intercostal muscles, mild tachypnea, no grunting -Moderate -two accessory muscles used, moderate indrawing of subcostal and intercostal muscles, moderate tachypnea, occasional grunting -Severe -use of all accessory muscles, severe indrawing of subcostal and intercostal muscles, severe tachypnea, regular grunting.
4. In the protocol, clinical management paragraph, they stated that "…all other treatment in both groups will be as per standard practice in the studies sites." Did they include analgo sedation?
